Afficher la couverture 'Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine | Dezoteux, Frédéric' en grand format
/5

0 avis

Herpes Zoster Following a Nucleoside-Modified Messenger RNA COVID-19 Vaccine

Archive ouverte

Dezoteux, Frédéric | Massip, Edouard | Marcant, Pierre | Sobaszek, Annie | Chopin, Marie-Charlotte | Vuotto, Fanny | Staumont, Delphine

Edité par CCSD ; Quadrant Health Com Inc -

International audience. Herpes zoster (HZ) was suspected as a predictive cutaneous manifestation of COVID-19, with a debated prognostic significance. We report a series of 5 cases of HZ occurring after vaccination with a nucleoside-modified messenger RNA (mRNA) COVID-19 vaccine (Comirnaty, Pfizer-BioNTech). These new cases do not prove causality between COVID-19 vaccination and HZ. The pathophysiologic mechanism remains elusive, but local vaccine-induced immunomodulation may be involved. The occurrence of HZ does not justify avoiding the second injection of vaccine due to the benefit of vaccination.

Consulter en ligne

Suggestions

Du même auteur

Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohort.

Archive ouverte | Massip, Edouard | CCSD

International audience

Occupational purpuric contact dermatitis to methylchloroisothiazolinone / methylisothiazolinone

Archive ouverte | Marcant, Pierre | CCSD

International audience

Absence of association between persistent skin lesion and virological replication in severe disseminated monkeypox infection in solid organ transplant recipient.

Archive ouverte | Rousseau, Arnaud | CCSD

International audience. The Monkeypox (mpox) virus outbreak has been controlled worldwide. We report the case of a combined pancreas-kidney transplant recipient who presented a severe and prolonged cutaneous infecti...

Chargement des enrichissements...